
    
The genomic variant c.2728C>T p.Gln910Ter rs794726721 in the SCN1A gene is a nonsense mutation resulting in the introduction of a premature termination codon at amino acid position 910 of the encoded protein. This variant has been identified in a female patient (P406) and is classified as likely pathogenic in ClinVar with two pathogenic submissions. The mutation is de novo, meaning it occurred spontaneously and was not inherited from either parent [3].The SCN1A gene encodes the alpha-1 subunit of the neuronal voltage-gated sodium channel Na_v1.1, which is essential for the initiation and propagation of action potentials in neurons. The proper functioning of Na_v1.1 is critical for maintaining the excitability of neurons, particularly in the central nervous system. Mutations in SCN1A can lead to a spectrum of epilepsy syndromes, ranging from relatively mild forms like Generalized Epilepsy with Febrile Seizures Plus (GEFS+) to more severe forms such as Dravet Syndrome (DS), which is characterized by frequent, prolonged seizures often triggered by fever, developmental delays, and other neurological deficits.Given the nature of the c.2728C>T p.Gln910Ter mutation, it is expected to result in a truncated protein product that lacks a significant portion of the C-terminal region, which may include transmembrane domains and the intracellular C-terminal domain critical for channel inactivation and interaction with intracellular partners. This loss of function can disrupt the normal sodium channel activity, leading to neuronal hyperexcitability and the clinical manifestations associated with SCN1A-related epilepsy syndromes. The stop-gained nature of this variant supports the hypothesis that truncated proteins resulting from nonsense mutations can lead to severe phenotypes by adversely affecting channel function [1].In summary, the c.2728C>T p.Gln910Ter rs794726721 variant in the SCN1A gene is a pathogenic mutation that likely causes a loss of function of the Na_v1.1 channel, contributing to the development of epilepsy and related neurological disorders.

SCN1A遺伝子におけるゲノム変異c.2728C>T p.Gln910Ter rs794726721はナンセンス変異であり、コードされたタンパク質のアミノ酸位置910に早期終止コドンを導入します。この変異は女性患者（P406）で確認されており、ClinVarでは2件の病原性提出に基づき「病原性の可能性が高い」と分類されています。この変異はde novo（新生）であり、両親のいずれからも遺伝していないことが示されています[3]。  
SCN1A遺伝子は、神経細胞の電位依存性ナトリウムチャネルNa_v1.1のα1サブユニットをコードしており、これは神経細胞における活動電位の開始と伝播に不可欠です。Na_v1.1の適切な機能は、特に中枢神経系における神経細胞の興奮性を維持するために重要です。SCN1Aの変異は、比較的軽度な「発熱性けいれんを伴う全般てんかん（GEFS+）」から、発熱による頻繁で長時間の発作、発達遅延、その他の神経学的欠損を特徴とするより重篤な「ドラベ症候群（DS）」まで、てんかん症候群のスペクトラムを引き起こす可能性があります。  
c.2728C>T p.Gln910Ter変異の性質を考えると、この変異はC末端領域の重要な部分を欠いた切断タンパク質を生成すると予想されます。この領域には、チャネルの不活性化や細胞内パートナーとの相互作用に重要な膜貫通ドメインや細胞内C末端ドメインが含まれる可能性があります。この機能喪失は、正常なナトリウムチャネル活性を妨げ、神経細胞の過剰興奮性を引き起こし、SCN1A関連てんかん症候群に関連する臨床症状をもたらす可能性があります。この変異の「ストップゲイン」性質は、ナンセンス変異による切断タンパク質がチャネル機能に悪影響を及ぼし、重篤な表現型を引き起こす可能性があるという仮説を支持します[1]。  
まとめると、SCN1A遺伝子のc.2728C>T p.Gln910Ter rs794726721変異は、Na_v1.1チャネルの機能喪失を引き起こす病原性変異であり、てんかんや関連する神経学的障害の発症に寄与していると考えられます。
    
## References
- [1] Viswanathan LG et al. (2023). "Phenotypic features of epilepsy due to sodium channelopathies - A single center experience from India." Journal of neurosciences in rural practice, 14(4) [PubMed](https://pubmed.ncbi.nlm.nih.gov/38059254/)
- [2] Orsini A et al. (2022). "Expanding Phenotype of Poirier-Bienvenu Syndrome: New Evidence from an Italian Multicentrical Cohort of Patients." Genes, 13(2) [PubMed](https://pubmed.ncbi.nlm.nih.gov/35205321/)
- [3] Fernandez-Marmiesse A et al. (2019). "Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients." Frontiers in neuroscience, 13() [PubMed](https://pubmed.ncbi.nlm.nih.gov/31780880/)
- [4] Encinas AC et al. (2020). "Variable patterns of mutation density among NaV1.1, NaV1.2 and NaV1.6 point to channel-specific functional differences associated with childhood epilepsy." PloS one, 15(8) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32845893/)

    
## ClinVar Submissions
- **[RCV000180827](https://www.ncbi.nlm.nih.gov/clinvar/RCV000180827/)**: Severe myoclonic epilepsy in infancy
- **[RCV000585857](https://www.ncbi.nlm.nih.gov/clinvar/RCV000585857/)**: Severe myoclonic epilepsy in infancy

    